Suzanne Bird
Direttore/Membro del Consiglio presso BIOREGENX, INC.
Patrimonio netto: 13 312 $ in data 31/05/2024
Profilo
Suzanne Bird is currently the Director at BioRegenx, Inc. She previously worked at BioRegenx, Inc. as a Director.
She completed her undergraduate degree at Southern Adventist University in 1985.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOREGENX INC
0.04% | 29/04/2024 | 416 000 ( 0.04% ) | 13 312 $ | 31/05/2024 |
Posizioni attive di Suzanne Bird
| Società | Posizione | Inizio |
|---|---|---|
| BIOREGENX, INC. | Direttore/Membro del Consiglio | 08/03/2024 |
Precedenti posizioni note di Suzanne Bird
| Società | Posizione | Fine |
|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direttore/Membro del Consiglio | - |
Formazione di Suzanne Bird
| Southern Adventist University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Findit, Inc. | |
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Borsa valori
- Insiders
- Suzanne Bird
